Performance of major liver resection for gallbladder cancer-a western retrospective single center cohort study.

ABSTRACT:

Background

Gallbladder cancer (GBCa) is a rare disease in western countries and surgery remains the state of art, given the tumor is technically resectable. However, data for major liver resection in patients with advanced GBCa is scarce. Objective of this study was to analyze survival outcome measures of patients undergoing major liver resection for GBCa.

Methods

We conducted a single center retrospective cohort study in a high volume hepato-pancreato-biliary (HPB) center screening all patients with gallbladder cancer (GBCa) being treated between 2008-2023. Inclusion criteria were met when resection [major hepatectomy (MaH); minor hepatectomy (MiH)] or palliative chemotherapy (either after surgical exploration +EL/sPC or primarily -EL/pPC) was performed at the

SUBMITTER: Scholz C 

PROVIDER: S-EPMC12690332 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature